JHW, D., T, F., & ZH, M. (2026). Preferential phosphodiesterase inhibition as a novel strategy to modulate key pathways in systemic sclerosis. Frontiers in immunology, 17, 1829186. https://doi.org/10.3389/fimmu.2026.1829186
Παραπομπή σε μορφή Chicago (17η εκδ.)JHW, Distler, Frech T, και McMahan ZH. "Preferential Phosphodiesterase Inhibition as a Novel Strategy to Modulate Key Pathways in Systemic Sclerosis." Frontiers in Immunology 17 (2026): 1829186. https://doi.org/10.3389/fimmu.2026.1829186.
Παραπομπή σε μορφή MLA (9th εκδ.)JHW, Distler, et al. "Preferential Phosphodiesterase Inhibition as a Novel Strategy to Modulate Key Pathways in Systemic Sclerosis." Frontiers in Immunology, vol. 17, 2026, p. 1829186, https://doi.org/10.3389/fimmu.2026.1829186.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.